Glenmark Pharmaceuticals on Friday announced that the leading research“based global pharmaceutical company has been granted final Abbreviated New Drug Application (ANDA) approval by the US Food and Drug Administration (USFDA) for Amlodipine and Olmesartan Medoxomil tablets, which are widely used to treat hypertension and high blood pressure.

The generic version of Azor tablets of Daiichi Sankyo registered sales of approximately $211.6 million in the 12 month period ending May 2017, according to data by IMS Health.

Currently, Glenmark is authorised to distribute 119 products in the US and and 66 ANDA approvals pending with the US drug regulator.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.